LB PharmaceuticalsLBRX
13F holders, Q4 2025 (December 31)68holders +15
30new positions
16sold out
1famous investor
$22.26avg. 13F price*
At the end of Q4 2025, 68 institutions reported holding LB Pharmaceuticals Inc. (LBRX) in their 13F filings, up 15 from Q3 2025. 30 opened new positions and 16 sold out. The largest holders were Deep Track Capital, LP ($74.6M), BlackRock, Inc. ($49.8M) and Ra Capital Management, L.P. ($49.2M). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- LB Pharmaceuticals Inc.
- CUSIP
- 50180M108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 30 | $46.4M |
| Exits | 16 | $22.5M |
All 13F filers, Q3 2025 → Q4 2025: 5,192,010 shares bought and 2,720,952 shares sold, net +2,471,058 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 68 holders
| Deep Track Capital, LP | 1.70% | No change | 3,352,804 | $74.6M |
| BlackRock, Inc. | 0.00% | Add +129.6% | 2,238,934 | $49.8M |
| Ra Capital Management, L.P. | 0.50% | Add +24.3% | 2,208,604 | $49.2M |
| TCG Crossover Management, LLC | 1.29% | Reduce 0.0% | 1,745,015 | $38.8M |
| JPMorgan Chase & Co. | 0.00% | Add +56.1% | 1,611,482 | $35.9M |
| Commodore Capital LP | 2.22% | No change | 1,500,000 | $33.4M |
| Trails Edge Capital Partners, LP | 7.68% | — | 1,395,608 | $31.1M |
| Logos Global Management LP | 1.78% | Add +6.2% | 1,200,000 | $26.7M |
| Vanguard Group Inc. | 0.00% | New | 1,112,978 | $24.8M |
| Spruce Street Capital LP | 7.40% | — | 1,005,593 | $22.4M |
| Balyasny Asset Management L.P. | 0.04% | Reduce -7.4% | 896,806 | $20.0M |
| Jennison Associates LLC | 0.01% | Add +11.2% | 821,852 | $18.3M |
| Vivo Capital, LLC | 1.15% | No change | 800,000 | $17.8M |
| Nantahala Capital Management, LLC | 0.90% | No change | 675,000 | $15.0M |
| Alyeska Investment Group, L.P. | 0.04% | No change | 675,000 | $15.0M |
| Geode Capital Management, LLC | 0.00% | Add +3148.1% | 441,454 | $9.8M |
| Citadel Advisors | 0.01% | Reduce -24.4% | 407,668 | $9.1M |
| Goldman Sachs Group Inc. | 0.00% | Reduce -11.8% | 303,115 | $6.7M |
| Nan Fung Group Holdings Ltd | 5.98% | No change | 300,000 | $6.7M |
| State Street Corp. | 0.00% | New | 250,030 | $5.6M |
| FMR LLC | 0.00% | Reduce -39.9% | 221,865 | $4.9M |
| Baker Bros. Advisors LP | 0.03% | No change | 200,000 | $4.5M |
| Ameriprise Financial Inc. | 0.00% | Add +149.9% | 193,544 | $4.3M |
| Charles Schwab Investment Management Inc. | 0.00% | New | 177,616 | $4.0M |
| Northern Trust Corp. | 0.00% | New | 143,966 | $3.2M |
| HighVista Strategies LLC | 0.80% | New | 140,107 | $3.1M |
| Integral Health Asset Management, LLC | 0.11% | No change | 100,000 | $2.2M |
| Longbow Finance SA | 0.31% | New | 82,336 | $1.8M |
| Boxer Capital Management, LLC | 0.34% | No change | 70,000 | $1.6M |
| UBS Group AG | 0.00% | Add +4706.9% | 50,713 | $1.1M |
| Bank of America Corp. | 0.00% | Add +2474.0% | 43,758 | $974K |
| Bank of New York Mellon Corp | 0.00% | New | 40,517 | $902K |
| Jane Street Group, LLC | 0.00% | Add +4.6% | 31,733 | $706K |
| Barclays PLC | 0.00% | Reduce -2.0% | 30,215 | $673K |
| Acuta Capital Partners, LLC | 0.45% | No change | 30,000 | $668K |
| Morgan Stanley | 0.00% | Add +156.5% | 24,641 | $549K |
| Nuveen, LLC | 0.00% | New | 22,966 | $511K |
| Wells Fargo & Company | 0.00% | Add +2130.3% | 22,303 | $496K |
| Focus Partners Wealth | 0.00% | New | 20,095 | $447K |
| Norges Bank | 0.00% | — | 20,000 | $445K |
| XTX Topco Ltd | 0.01% | Add +69.6% | 19,121 | $426K |
| Marshall Wace, LLP | 0.00% | Reduce -93.0% | 18,014 | $401K |
| Rhumbline Advisers | 0.00% | New | 16,283 | $362K |
| Deutsche Bank AG | 0.00% | New | 13,298 | $296K |
| Two Sigma Investments, LP | 0.00% | Reduce -5.8% | 12,720 | $283K |
| Jefferies Financial Group Inc. | 0.00% | Reduce -5.0% | 12,445 | $277K |
| MetLife Investment Management, LLC | 0.00% | New | 11,104 | $247K |
| T. Rowe Price Associates Inc. | 0.00% | Reduce -96.1% | 11,074 | $247K |
| Invesco Ltd. | 0.00% | New | 10,955 | $244K |
| Soleus Capital Management, L.P. | 0.01% | Reduce -97.5% | 10,000 | $223K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 8,966 | $200K |
| SG Americas Securities, LLC | 0.00% | New | 6,434 | $143K |
| Federated Hermes, Inc. | 0.00% | Reduce -44.4% | 5,000 | $111K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | New | 4,425 | $99K |
| Persistent Asset Partners Ltd | 0.04% | New | 4,080 | $91K |
| BNP Paribas Financial Markets | 0.00% | New | 4,007 | $89K |
| STRS Ohio | 0.00% | New | 3,400 | $76K |
| Legal & General Group Plc | 0.00% | New | 1,878 | $42K |
| Ameritas Investment Partners, Inc. | 0.00% | New | 1,562 | $35K |
| Russell Investments Group, Ltd. | 0.00% | New | 1,525 | $34K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,361 | $30K |
| California State Teachers Retirement System | 0.00% | New | 1,184 | $26K |
| Royal Bank of Canada | 0.00% | New | 767 | $17K |
| Sterling Capital Management LLC | 0.00% | New | 592 | $13K |
| Amalgamated Bank | 0.00% | New | 605 | $13K |
| Citigroup Inc. | 0.00% | New | 435 | $10K |
| GAMMA Investing LLC | 0.00% | New | 14 | $312 |
| Cwm, LLC | 0.00% | New | 8 | $0 |
"% of holder's portfolio" is LBRX's weight in each manager's 13F, not the share of LB Pharmaceuticals Inc. the manager owns.